🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

India asks states to halt online drug sales

Published 12/04/2019, 04:10 AM
Updated 12/04/2019, 04:16 AM
India asks states to halt online drug sales

By Aditya Kalra and Savio Shetty

NEW DELHI/MUMBAI (Reuters) - India's drugs regulator has asked all states to enforce a court directive prohibiting online medicine sales, a senior government official said on Wednesday, raising industry concerns it could disrupt some online businesses.

India is yet to finalize regulations for online drug sales, or e-pharmacies, but the growth of several online sellers such as Medlife, Netmeds, Temasek-backed PharmEasy and Sequoia Capital-backed 1mg has threatened traditional drug-store businesses.

The Delhi High Court in December last year said the government must ensure online sales are prohibited for the time being, as it heard a petition from a doctor who alleged unregulated online sales could lead to abuse of medicines.

K. Bangarurajan, a senior official at the Central Drugs Standard Control Organisation (CDSCO), said the federal agency had asked states earlier this year to comply with the court's order, and a reminder had now been issued to all authorities.

"State drug controllers are the regulating authority, they have to implement this ... and if anyone is dealing (in online sales) they need to take action," Bangarurajan told Reuters.

The CDSCO's directive was sent on Nov. 28 to all states, according to a copy seen by Reuters. It was not immediately clear what subsequent action states would take.

Sreenidhi Srinivasan, a senior associate at law firm Ikigai Law, said the Delhi court order had raised concerns in the industry and any bans by state drug controllers could hurt online sellers.

Trader groups have protested for years against e-pharmacies, saying they challenge their businesses and could allow medicines to be abused by being sold without proper verification. They also allege e-pharmacies make it easier to use one prescription to buy medicines multiple times.

Steep online discounts have also hit offline businesses, which according to industry estimates recorded $18.4 billion in retail sales in 2018-19. Sales growth has averaged only 8.2% a year since 2015-2016, when sales grew by 12.3%.

"Online retailers have been offering discounts more than our margins," said Yash Aggarwal, legal head of South Chemists and Distributors Association in New Delhi.

Some are not worried, however. Pradeep Dadha, CEO and founder of online e-pharmacy Netmeds, said his firm was complying with all Indian laws and regulations and business was continuing as usual.

"All our partner pharmacies also have the required licenses," Dadha said.

(This story corrects day in paragraph 1 to Wednesday from Tuesday)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.